• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis
Hemorrhagic transformation (HT) is a multifactorial phenomenon and represents a possible complication of ischemic stroke, especially after thrombolytic treatment. Increased arterial stiffness has been associated with intracranial hemorrhage, but there is no evidence of association with HT after thrombolytic therapy. The aim of our study is to investigate a possible link between arterial stiffness and HT occurrence after thrombolytic therapy in patients with ischemic stroke.
Source: International Journal of Cardiology - July 23, 2017 Category: Cardiology Authors: Maurizio Acampa, Silvia Camarri, Pietro Enea Lazzerini, Francesca Guideri, Rossana Tassi, Raffaella Valenti, Alessandra Cartocci, Giuseppe Martini Source Type: research

Electrocardiographic differentiation between takotsubo syndrome and acute myocardial infarction
It is crucial to differentiate between acute myocardial infarction (AMI), particularly of the ST-segment elevation (STE) AMI variety, and takotsubo syndrome (TTS), in order as swiftly as possible to implement thrombolytic therapy and/or percutaneous coronary interventions for the former. Also the potential benefits accrued by such an early diagnostic differentiation has a bearing on the urgency and timing of coronary arteriography, and the use of antiplatelet/anticoagulation regimen, particularly in patients “with multiple comorbidities such as those presenting after physical stressors such as subarachnoid hemorrhage or ...
Source: International Journal of Cardiology - August 7, 2016 Category: Cardiology Authors: John E. Madias Source Type: research

Interventional Cardiologists in the Treatment of Acute Ischemic Stroke: New Players in the Game
Ischemic stroke is a devastating condition with a high burden of neurologic disability and death. Multiple randomized controlled trials have shown the efficacy of intravenous thrombolysis up to 4.5hours from onset in patients with acute ischemic stroke (1). However, the utility and efficacy of thrombolytic therapy in acute stroke management is limited by a narrow time window for treatment, thrombus burden and patient related thrombolytic contraindications (2,3).
Source: International Journal of Cardiology - September 25, 2015 Category: Cardiology Authors: Mehmet Ergelen, Huseyin Uyarel Source Type: research